Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
Journal of Medicinal Chemistry
|
October 15, 1993
3-(Alkylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as powerful inhibitors of insulin release from rat pancreatic B-cells: a new class of potassium channel openers?
B Pirotte, P de Tullio, P Lebrun, et al.
British Journal of Cancer
|
April 3, 2003
3-Bromophenyl 6-acetoxymethyl-2-oxo-2H-1-benzopyran-3-carboxylate inhibits cancer cell invasion in vitro and tumour growth in vivo
I Kempen, D Papapostolou, N Thierry, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
January 23, 2003
Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation
X de Leval, V Benoit, J Delarge, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 10, 1998
Pyridothiadiazinedioxides structurally related to quinazolinones cholecystokinin/gastrin receptor ligands: synthesis and biological evaluation
B Pirotte, P de Tullio, T Podona, et al.
British Journal of Pharmacology
|
September 21, 2001
Synthesis and characterization of a quinolinonic compound activating ATP-sensitive K(+) channels in endocrine and smooth muscle tissues
B Becker, M H Antoine, Q A Nguyen, et al.
Biochemical and Molecular Medicine
|
February 1, 1996
The riddle of formycin A insulinotropic action
W J Malaisse, P Lebrun, B Pirotte, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
June 22, 2001
Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood
X de Leval, J Delarge, P Devel, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
January 23, 2003
Pharmacological evaluation of the novel thromboxane modulator BM-567 (I/II). Effects of BM-567 on platelet function
J M Dogné, X de Leval, P Kolh, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1996
Activation of ATP-dependent K+ channels and inhibition of insulin release: effect of BPDZ 62
P Lebrun, M H Antoine, R Ouedraogo, et al.
Journal of Medicinal Chemistry
|
July 31, 1998
4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors: design, synthesis, pharmacology, and structure-activity relationships
B Pirotte, T Podona, O Diouf, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
Journal of Medicinal Chemistry
|
October 15, 1993
3-(Alkylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as powerful inhibitors of insulin release from rat pancreatic B-cells: a new class of potassium channel openers?
B Pirotte, P de Tullio, P Lebrun, et al.
British Journal of Cancer
|
April 3, 2003
3-Bromophenyl 6-acetoxymethyl-2-oxo-2H-1-benzopyran-3-carboxylate inhibits cancer cell invasion in vitro and tumour growth in vivo
I Kempen, D Papapostolou, N Thierry, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
January 23, 2003
Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation
X de Leval, V Benoit, J Delarge, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 10, 1998
Pyridothiadiazinedioxides structurally related to quinazolinones cholecystokinin/gastrin receptor ligands: synthesis and biological evaluation
B Pirotte, P de Tullio, T Podona, et al.
British Journal of Pharmacology
|
September 21, 2001
Synthesis and characterization of a quinolinonic compound activating ATP-sensitive K(+) channels in endocrine and smooth muscle tissues
B Becker, M H Antoine, Q A Nguyen, et al.
Biochemical and Molecular Medicine
|
February 1, 1996
The riddle of formycin A insulinotropic action
W J Malaisse, P Lebrun, B Pirotte, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
June 22, 2001
Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood
X de Leval, J Delarge, P Devel, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
January 23, 2003
Pharmacological evaluation of the novel thromboxane modulator BM-567 (I/II). Effects of BM-567 on platelet function
J M Dogné, X de Leval, P Kolh, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1996
Activation of ATP-dependent K+ channels and inhibition of insulin release: effect of BPDZ 62
P Lebrun, M H Antoine, R Ouedraogo, et al.
Journal of Medicinal Chemistry
|
July 31, 1998
4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors: design, synthesis, pharmacology, and structure-activity relationships
B Pirotte, T Podona, O Diouf, et al.
Page
of 9